You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 25, 2024

UPNEEQ Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Upneeq, and when can generic versions of Upneeq launch?

Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are twelve patents protecting this drug.

This drug has forty-nine patent family members in twenty-eight countries.

The generic ingredient in UPNEEQ is oxymetazoline hydrochloride. There are three drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the oxymetazoline hydrochloride profile page.

DrugPatentWatch® Generic Entry Outlook for Upneeq

Indicators of Generic Entry

< Available with Subscription >

  Try a Trial

US Patents and Regulatory Information for UPNEEQ

UPNEEQ is protected by twelve US patents.

Patents protecting UPNEEQ

Compositions and methods for treating ocular disorders
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS

Oxymetazoline compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Oxymetazoline compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Compositions and methods for non-surgical treatment of ptosis
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS

Compositions and methods for treating ocular disorders
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Oxymetazoline compositions
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial

Compositions and methods for treating ocular disorders
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial


Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS

Compositions and methods for non-surgical treatment of ptosis
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS

Compositions and methods for non-surgical treatment of Ptosis
Patent Number: ⤷  Try a Trial
Patent Expiration: ⤷  Try a Trial
Patented Use: METHOD OF TREATING BLEPHAROPTOSIS

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial Y ⤷  Try a Trial
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Rvl Pharms UPNEEQ oxymetazoline hydrochloride SOLUTION/DROPS;OPHTHALMIC 212520-001 Jul 8, 2020 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for UPNEEQ

When does loss-of-exclusivity occur for UPNEEQ?

Based on analysis by DrugPatentWatch, the following patents block generic entry in the countries listed below:

Australia

Patent: 20268329
Estimated Expiration: ⤷  Try a Trial

Brazil

Patent: 2021022404
Estimated Expiration: ⤷  Try a Trial

Canada

Patent: 39443
Estimated Expiration: ⤷  Try a Trial

Chile

Patent: 21002918
Estimated Expiration: ⤷  Try a Trial

China

Patent: 1888326
Estimated Expiration: ⤷  Try a Trial

Patent: 7045596
Estimated Expiration: ⤷  Try a Trial

Colombia

Patent: 21015265
Estimated Expiration: ⤷  Try a Trial

European Patent Office

Patent: 65737
Estimated Expiration: ⤷  Try a Trial

Israel

Patent: 7831
Estimated Expiration: ⤷  Try a Trial

Japan

Patent: 41420
Estimated Expiration: ⤷  Try a Trial

Patent: 20183373
Estimated Expiration: ⤷  Try a Trial

Patent: 21191802
Estimated Expiration: ⤷  Try a Trial

Mexico

Patent: 21013516
Estimated Expiration: ⤷  Try a Trial

Morocco

Patent: 895
Estimated Expiration: ⤷  Try a Trial

Peru

Patent: 220384
Estimated Expiration: ⤷  Try a Trial

Singapore

Patent: 202112272T
Estimated Expiration: ⤷  Try a Trial

South Africa

Patent: 2108950
Estimated Expiration: ⤷  Try a Trial

South Korea

Patent: 2410503
Estimated Expiration: ⤷  Try a Trial

Patent: 200128629
Estimated Expiration: ⤷  Try a Trial

Patent: 220084264
Estimated Expiration: ⤷  Try a Trial

Generics may enter earlier, or later, based on new patent filings, patent extensions, patent invalidation, early generic licensing, generic entry preferences, and other factors.

See the table below for additional patents covering UPNEEQ around the world.

Country Patent Number Title Estimated Expiration
South Africa 202108950 OXYMETAZOLINE COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS ⤷  Try a Trial
Mexico 2021013516 COMPOSICIONES Y MÉTODOS DE OXIMETAZOLINA PARA EL TRATAMIENTO DE TRASTORNOS OCULARES. (OXYMETAZOLINE COMPOSITIONS AND METHODS FOR TREATING OCULAR DISORDERS.) ⤷  Try a Trial
Mexico 2013009597 COMPOSICIONES Y METODOS PARA TRATAMIENTO NO QUIRURGICO DE PTOSIS. (COMPOSITIONS AND METHODS FOR NON-SURGICAL TREATMENT OF PTOSIS.) ⤷  Try a Trial
Japan 7141420 ⤷  Try a Trial
Poland 2680829 ⤷  Try a Trial
China 111888326 羟甲唑啉组合物和用于治疗眼障碍的方法 (Compositions and methods for treating ocular disorders) ⤷  Try a Trial
Chile 2021002918 Composiciones y métodos de oximetazolina para el tratamiento de trastornos oculares ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.